IGF-1 LR3 Research Guide
1mg · Research compound — not for human consumption
Research Overview
IGF-1 LR3 (Long Arg3 Insulin-like Growth Factor-1) is a synthetic 83-amino-acid analog of native IGF-1 that has been studied in laboratory settings as a tool for probing IGF-1 receptor signaling. Its structural modifications extend its in-vitro stability relative to native IGF-1. It is a research compound not intended for human consumption.
Structural & Class Overview
Modified single-chain polypeptide analog of the IGF-1 family; features an arginine-for-glutamic-acid substitution at position 3 plus a 13-residue N-terminal extension, which lower its affinity for IGF-binding proteins (IGFBPs). Mechanistically it is an agonist-class ligand of the IGF-1 receptor (IGF-1R), a receptor tyrosine kinase.
General Research Interest
Research interest includes IGF-1R receptor-tyrosine-kinase signaling pathways; interactions with IGF-binding proteins and altered ligand bioavailability in cell models; downstream PI3K/Akt and MAPK signaling studies; models of cell proliferation and differentiation; and comparative pharmacokinetic characterization versus native IGF-1 in preclinical assays.
Storage Considerations
General research-handling for a lyophilized peptide: store lyophilized material cold and protected from light and moisture; after reconstitution in a suitable laboratory solvent, keep refrigerated and minimize freeze-thaw cycles. For laboratory use only.
Testing & Quality Considerations
Quality considerations include HPLC assessment of purity, mass spectrometry for identity/molecular-weight confirmation, and verification of batch-specific Certificates of Analysis (COA) for peptide content and endotoxin where applicable.
References
References are provided for scientific context. Linked sources are independent and not affiliated with iNGEN MD.
